The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Open accessAbstract
Glycosylation is a well-regulated cell and microenvironment specific post-translational modification. Several glycosyltransferases and glycosidases orchestrate the addition of defined glycan structures on the proteins and lipids. Recent advances and systemic approaches in glycomics have significantly contributed to a better understanding of instrumental roles of glycans in health and diseases. Emerging research evidence recognized aberrantly glycosylated proteins as the modulators of the malignant phenotype of cancer cells. The Cancer Genome Atlas has identified alterations in the expressions of glycosylation-specific genes that are correlated with cancer progression. However, the mechanistic basis remains poorly explored. Recent researches have shown that specific changes in the glycan structures are associated with ‘stemness’ and epithelial-to-mesenchymal transition of cancer cells. Moreover, epigenetic changes in the glycosylation pattern make the tumor cells capable of escaping immunosurveillance mechanisms. The deciphering roles of glycans in cancer emphasize that glycans can serve as a source for the development of novel clinical biomarkers. The ability of glycans in intervening various stages of tumor progression and the biosynthetic pathways involved in glycan structures constitute a promising target for cancer therapy. Advances in the knowledge of innovative strategies for identifying the mechanisms of glycan-binding proteins are hoped to hold great potential in cancer therapy. This review discusses the fundamental role of glycans in regulating tumorigenesis and tumor progression and provides insights into the influence of glycans in the current tactics of targeted therapies in the clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liu, B., Pan, S., Xiao, Y., Liu, Q., Xu, J., & Li, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0994-x · Cited by 122
RetractedWiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635 · cited 1×
“However, the past two decades of research provide remarkable progress in understanding the biology and pathology of glycosylation [2].”
BackgroundIntracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., & Knapp, R. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110380 · Cited by 1,661
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
Spiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,409
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Purification of a Human Prostate Specific Antigen
Wang, M. C., Valenzuela, L. A., Murphy, G. P., & Chu, T. M. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.100 · Cited by 825
Concepts and Principles of O-Linked Glycosylation
Steen, P. V. D., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204198 · Cited by 760
Mechanisms and principles of N-linked protein glycosylation
Schwarz, F., & Aebi, M. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.005 · Cited by 695
KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.223 · Cited by 573
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN
WANG, M. C., VALENZUELA, L. A., MURPHY, G. P., & CHU, T. M. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65270-6 · Cited by 550
Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M., & Kannagi, R. (1993) · PubMed · Cited by 544
Advances in the Biology and Chemistry of Sialic Acids
Chen, X., & Varki, A. (2010) · ACS Chemical Biology · doi:10.1021/cb900266r · Cited by 543
Chemical Biology of the Sugar Code
Gabius, H., Siebert, H., André, S., Jiménez‐Barbero, J., & Rüdiger, H. (2004) · ChemBioChem · doi:10.1002/cbic.200300753 · Cited by 524
Hallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
The repertoire of glycan determinants in the human glycome
Cummings, R. D. (2009) · Molecular BioSystems · doi:10.1039/b907931a · Cited by 487
Genetic defects in the human glycome
Freeze, H. H. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1894 · Cited by 467
Ferrer, C. M., Lynch, T. P., Sodi, V. L., Falcone, J. N., Schwab, L. P., Peacock, D. L., Vocadlo, D. J., Seagroves, T. N., & Reginato, M. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.026 · Cited by 442
Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P., Sethi, G., Walker, S., Vosseller, K., & Reginato, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.41 · Cited by 396
Ruiz-Canada, C., Kelleher, D. J., & Gilmore, R. (2009) · Cell · doi:10.1016/j.cell.2008.11.047 · Cited by 391
Altered Tumor-Cell Glycosylation Promotes Metastasis
Häuselmann, I., & Borsig, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00028 · Cited by 382
Robust immune responses elicited by a fully synthetic three-component vaccine
Ingale, S., Wolfert, M. A., Gaekwad, J., Buskas, T., & Boons, G.-J. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.25 · Cited by 337
O-Glycosylation of the Mucin Type
Hanisch, F.-G. (2001) · Biological Chemistry · doi:10.1515/bc.2001.022 · Cited by 322
Seales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J. K., Frost, A. R., & Bellis, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3117 · Cited by 317
The role of protein glycosylation in Alzheimer disease
Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014) · The FEBS Journal · doi:10.1111/febs.12590 · Cited by 317
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406619111 · Cited by 313
Self-citationA Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis
Agrawal, P., Fontanals-Cirera, B., Sokolova, E., Jacob, S., Vaiana, C. A., Argibay, D., Davalos, V., McDermott, M., Nayak, S., Darvishian, F., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.007 · Cited by 303
PSA and beyond: alternative prostate cancer biomarkers
Saini, S. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0268-6 · Cited by 295
Yoshimura, M., Nishikawa, A., Ihara, Y., Taniguchi, S., & Taniguchi, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8754 · Cited by 292
Lynch, T. P., Ferrer, C. M., Jackson, S. R., Shahriari, K. S., Vosseller, K., & Reginato, M. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302547 · Cited by 286
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Läubli, H., & Borsig, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02120 · Cited by 282
Duffy, M. J., McGowan, P. M., Harbeck, N., Thomssen, C., & Schmitt, M. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0428-4 · Cited by 273
Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
Tolcher, A. W., Sugarman, S., Gelmon, K. A., Cohen, R., Saleh, M., Isaacs, C., Young, L., Healey, D., Onetto, N., & Slichenmyer, W. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.478 · Cited by 271
Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer
Chen, C.-Y., Jan, Y.-H., Juan, Y.-H., Yang, C.-J., Huang, M.-S., Yu, C.-J., Yang, P.-C., Hsiao, M., Hsu, T.-L., & Wong, C.-H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220425110 · Cited by 266
Targeting Glycosylation: A New Road for Cancer Drug Discovery
Costa, A. F., Campos, D., Reis, C. A., & Gomes, C. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.04.002 · Cited by 263
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., & Yu, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.009 · Cited by 259
Unmasking Fucosylation: from Cell Adhesion to Immune System Regulation and Diseases
Li, J., Hsu, H.-C., Mountz, J. D., & Allen, J. G. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.02.005 · Cited by 256
Slovin, S. F., Ragupathi, G., Adluri, S., Ungers, G., Terry, K., Kim, S., Spassova, M., Bornmann, W. G., Fazzari, M., Dantis, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5710 · Cited by 252
Zhang, J., Chen, G., Zhang, P., Zhang, J., Li, X., Gan, D., Cao, X., Han, M., Du, H., & Ye, Y. (2020) · PLOS ONE · doi:10.1371/journal.pone.0228857 · Cited by 249
Sialylation of N-glycans: mechanism, cellular compartmentalization and function
Bhide, G. P., & Colley, K. J. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1520-x · Cited by 238
Branched N‐glycans regulate the biological functions of integrins and cadherins
Zhao, Y., Sato, Y., Isaji, T., Fukuda, T., Matsumoto, A., Miyoshi, E., Gu, J., & Taniguchi, N. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06346.x · Cited by 236
Alteration of protein glycosylation in liver diseases
Blomme, B., Van Steenkiste, C., Callewaert, N., & Van Vlierberghe, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.010 · Cited by 225
FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation
Tu, C.-F., Wu, M.-Y., Lin, Y.-C., Kannagi, R., & Yang, R.-B. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0904-8 · Cited by 225
Development of Globo-H Cancer Vaccine
Danishefsky, S. J., Shue, Y., Chang, M. N. T., & Wong, C. (2015) · Accounts of Chemical Research · doi:10.1021/ar5004187 · Cited by 224
Oligosaccharides Expressed on MUC1 Produced by Pancreatic and Colon Tumor Cell Lines
Burdick, M. D., Harris, A., Reid, C. J., Iwamura, T., & Hollingsworth, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24198 · Cited by 215
GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis
Gu, Y., Mi, W., Ge, Y., Liu, H., Fan, Q., Han, C., Yang, J., Han, F., Lu, X., & Yu, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1887 · Cited by 215
Luo, J., Shen, L., & Zheng, D. (2014) · Scientific Reports · doi:10.1038/srep06269 · Cited by 212
Anti-GD2 immunotherapy for neuroblastoma
Sait, S., & Modak, S. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1364995 · Cited by 210
Regulation of Glycan Structures in Animal Tissues
Nairn, A. V., York, W. S., Harris, K., Hall, E. M., Pierce, J. M., & Moremen, K. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801964200 · Cited by 206
Gilewski, T., Ragupathi, G., Bhuta, S., Williams, L. J., Musselli, C., Zhang, X.-F., Bencsath, K. P., Panageas, K. S., Chin, J., Hudis, C. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626298 · Cited by 205
Julien, S., Adriaenssens, E., Ottenberg, K., Furlan, A., Courtand, G., Vercoutter-Edouart, A.-S., Hanisch, F.-G., Delannoy, P., & Le Bourhis, X. (2006) · Glycobiology · doi:10.1093/glycob/cwj033 · Cited by 204
Sokoll, L. J., Sanda, M. G., Feng, Z., Kagan, J., Mizrahi, I. A., Broyles, D. L., Partin, A. W., Srivastava, S., Thompson, I. M., Wei, J. T., et al. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0007 · Cited by 202
Practice Guidelines for Tumor Marker Use in the Clinic
Sturgeon, C. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1151 · Cited by 202
Estrogen receptor: A prognostic factor in breast cancer
Samaan, N. A., Buzdar, A. U., Aldinger, K. A., Schultz, P. N., Yang, K.-P., Romsdahl, M. M., & Martin, R. G. (1981) · Cancer · doi:10.1002/1097-0142(19810201)47:3<554::aid-cncr2820470322>3.0.co;2-w · Cited by 189
CA19-9 for detecting recurrence of pancreatic cancer
Azizian, A., Rühlmann, F., Krause, T., Bernhardt, M., Jo, P., König, A., Kleiß, M., Leha, A., Ghadimi, M., & Gaedcke, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-57930-x · Cited by 182
Synthesis of GDP-L-fucose by the Human FX Protein
Tonetti, M., Sturla, L., Bisso, A., Benatti, U., & De Flora, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27274 · Cited by 173
MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., & Gendler, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206291 · Cited by 173
Buskas, T., Li, Y., & Boons, G. (2004) · Chemistry – A European Journal · doi:10.1002/chem.200400074 · Cited by 172
Defective glycosylation in muscular dystrophy
Muntoni, F., Brockington, M., Blake, D. J., Torelli, S., & Brown, S. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11397-3 · Cited by 170
Brockhausen, I., & Stanley, P. (2009) · Europe PMC (PubMed Central) · doi:10.1101/glycobiology.3e.010 · Cited by 169
Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis
Nguyen, A. T., Chia, J., Ros, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.001 · Cited by 168
Current trends in the structure-activity relationships of sialyltransferases
Audry, M., Jeanneau, C., Imberty, A., Harduin-Lepers, A., Delannoy, P., & Breton, C. (2011) · Glycobiology · doi:10.1093/glycob/cwq189 · Cited by 167
Schultz, M. J., Holdbrooks, A. T., Chakraborty, A., Grizzle, W. E., Landen, C. N., Buchsbaum, D. J., Conner, M. G., Arend, R. C., Yoon, K. J., Klug, C. A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2834 · Cited by 164
Glycosylation Characteristics of Colorectal Cancer
Holst, S., Wuhrer, M., & Rombouts, Y. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.004 · Cited by 160
Disialoganglioside GD2 as a therapeutic target for human diseases
Suzuki, M., & Cheung, N. V. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.986459 · Cited by 156
Guo, H., Lee, I., Kamar, M., & Pierce, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308837200 · Cited by 153
Carvalho, S., Catarino, T. A., Dias, A. M., Kato, M., Almeida, A., Heßling, B., Figueiredo, J., Gärtner, F., Sanches, J., Ruppert, T., et al. (2015) · Oncogene · doi:10.1038/onc.2015.225 · Cited by 151
Protein O-fucosylation: structure and function
Holdener, B. C., & Haltiwanger, R. S. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.12.005 · Cited by 148
Buskas, T., Ingale, S., & Boons, G. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501818 · Cited by 145
Patra, M., Awuah, S. G., & Lippard, S. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06937 · Cited by 145
Chromogranin A—unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls
Gut, P., Czarnywojtek, A., Fischbach, J., Bączyk, M., Ziemnicka, K., Wrotkowska, E., Gryczyńska, M., & Ruchała, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.57577 · Cited by 144
N-Glycosylation Affects the Molecular Organization and Stability of E-cadherin Junctions
Liwosz, A., Lei, T., & Kukuruzinska, M. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512621200 · Cited by 144
Glycosylation Changes in Brain Cancer
Veillon, L. J., Fakih, C., Abou‐El‐Hassan, H., Kobeissy, F. H., & Mechref, Y. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00271 · Cited by 142
Murata, K., Miyoshi, E., Kameyama, M., Ishikawa, O., Kabuto, T., Sasaki, Y., Hiratsuka, M., Ohigashi, H., Ishiguro, S., Ito, S., et al. (2000) · PubMed · Cited by 138
Core fucosylation of E‐cadherin enhances cell–cell adhesion in human colon carcinoma WiDr cells
Osumi, D., Takahashi, M., Miyoshi, E., Yokoe, S., Lee, S. H., Noda, K., Nakamori, S., Gu, J., Ikeda, Y., Kuroki, Y., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01125.x · Cited by 137
Chen, J.-Y., Tang, Y.-A., Huang, S.-M., Juan, H., Wu, L., Sun, Y., Wang, S.-C., Wu, K.-W., Gopula, B., Chang, T.-T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1303 · Cited by 136
Vaccination with Theratope® (STn-KLH) as treatment for breast cancer
Holmberg, L., & Sandmaier, B. M. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.6.655 · Cited by 133
Medicinal Chemistry of Paclitaxel and its Analogues
Fu, Y., Li, S., Zu, Y., Yang, G., Yang, Z., Luo, M., Jiang, S., Wink, M., & Efferth, T. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789352277 · Cited by 132
Sialylation: an Avenue to Target Cancer Cells
Vajaria, B. N., Patel, K. R., Begum, R., & Patel, P. S. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-0033-6 · Cited by 131
Pohl, J., Bertram, B., Hilgard, P., Nowrousian, M. R., Stüben, J., & Wießler, M. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050248 · Cited by 130
Kudryashov, V., Glunz, P. W., Williams, L. J., Hintermann, S., Danishefsky, S. J., & Lloyd, K. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051623598 · Cited by 128
Polysaccharides for the Delivery of Antitumor Drugs
Posocco, B., Dreussi, E., Santa, J. D., Toffoli, G., Abrami, M., Musiani, F., Grassi, M., Farra, R., Tonon, F., Grassi, G., et al. (2015) · Materials · doi:10.3390/ma8052569 · Cited by 126
Menni, C., Gudelj, I., Macdonald-Dunlop, E., Mangino, M., Zierer, J., Bešić, E., Joshi, P. K., Trbojević‐Akmačić, I., Chowienczyk, P., Spector, T. D., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312174 · Cited by 126
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann, B. T., Schlüter, L., Lange, P. F., Mercanoglu, B., Ewald, F., Fölster, A., Picksak, A.-S., Harder, S., Gammal, A. T. E., Grupp, K., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0386-1 · Cited by 125
Comparison of the Transmembrane Mucins MUC1 and MUC16 in Epithelial Barrier Function
Gipson, I. K., Spurr-Michaud, S. J., Tisdale, A. S., & Menon, B. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100393 · Cited by 124
Cheng, H., Cao, X., Xian, M., Fang, L., Cai, T., Ji, J. J., Tunac, J. B., Sun, D., & Wang, P. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049693a · Cited by 119
Yang, X., Yang, Y., Li, Z., Chen, C., Yang, T., Wang, C., Liu, L., & Liu, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124884 · Cited by 117
Slovin, S. F., Ragupathi, G., Musselli, C., Fernandez, C., Diani, M., Verbel, D., Danishefsky, S. J., Livingston, P. O., & Scher, H. I. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0598-5 · Cited by 116
Lu, J., Isaji, T., Im, S., Fukuda, T., Hashii, N., Takakura, D., Kawasaki, N., & Gu, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593392 · Cited by 114
Glycosylation diseases: Quo vadis?
Schachter, H., & Freeze, H. H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.002 · Cited by 114
Schneider, F., Kemmner, W., Haensch, W., Franke, G., Gretschel, S., Karsten, U. R., & Schlag, P. M. (2001) · PubMed · Cited by 113
Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V
Nagae, M., Kizuka, Y., Mihara, E., Kitago, Y., Hanashima, S., Ito, Y., Takagi, J., Taniguchi, N., & Yamaguchi, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-05931-w · Cited by 113
Martínez‐Sáez, N., Peregrina, J. M., & Corzana, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00858e · Cited by 112
Comamala, M., Pinard, M., Thériault, C., Matte, I., Albert, A., Boivin, M., Beaudin, J., Piché, A., & Rancourt, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.34 · Cited by 111
Ingale, S., Wolfert, M. A., Buskas, T., & Boons, G. (2009) · ChemBioChem · doi:10.1002/cbic.200800596 · Cited by 108
Gynther, M., Ropponen, J., Laine, K., Leppänen, J., Haapakoski, P., Peura, L., Järvinen, T., & Rautio, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015409 · Cited by 106
New trends in guided nanotherapies for digestive cancers: A systematic review
Fernandes, E., Ferreira, J. A., Peixoto, A., Luís, L., Barroso, S., Sarmento, B. F. C. C., & Santos, L. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.003 · Cited by 102
Toyokuni, T., Dean, B., Cai, S., Boivin, D., Hakomori, S., & Singhal, A. K. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00080a055 · Cited by 101
From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine
Zhu, J., Wan, Q., Lee, D., Yang, G., Spassova, M. K., Ouerfelli, O., Ragupathi, G., Damani, P., Livingston, P. O., & Danishefsky, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901415s · Cited by 100
Fei, G. E. N. G., Shi, B. Z., Yuan, Y., & Wu, X. (2004) · Cell Research · doi:10.1038/sj.cr.7290243 · Cited by 98
Cai, H., Sun, Z., Huang, Z., Shi, L., Zhao, Y., Kunz, H., & Li, Y. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201203709 · Cited by 98
Scott, A. M., Geleick, D., Rubira, M. R., Clarke, K., Nice, E. C., Smyth, F. E., Stockert, E., Richards, E. C., Carr, F. J., Harris, W. J., et al. (2000) · PubMed · Cited by 97
Madjd, Z., Parsons, T., Watson, N. F., Spendlove, I., Ellis, I. O., & Durrant, L. G. (2005) · Breast Cancer Research · doi:10.1186/bcr1305 · Cited by 96
Xu, Q., Isaji, T., Lu, Y., Gu, W., Kondo, M., Fukuda, T., Du, Y., & Gu, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262154 · Cited by 96
Glycan Antagonists and Inhibitors: A Fount for Drug Discovery
Brown, J. R., Crawford, B. E., & Esko, J. D. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701751611 · Cited by 94
Champattanachai, V., Netsirisawan, P., Chaiyawat, P., Phueaouan, T., Charoenwattanasatien, R., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., & Svasti, J. (2013) · PROTEOMICS · doi:10.1002/pmic.201200126 · Cited by 93
Hirakawa, M., Takimoto, R., Tamura, F., Yoshida, M., Ono, M., Murase, K., Sato, Y., Osuga, T., Sato, T., Iyama, S., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.699 · Cited by 90
Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes
Ashkani, J., & Naidoo, K. J. (2016) · Scientific Reports · doi:10.1038/srep26451 · Cited by 90
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling
Jones, R. B., Dorsett, K. A., Hjelmeland, A. B., & Bellis, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001194 · Cited by 87
Zhou, Z., Liao, G., Mandal, S. S., Suryawanshi, S., & Guo, Z. (2015) · Chemical Science · doi:10.1039/c5sc01402f · Cited by 86
Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex
Cao, J., Cui, S., Li, S., Du, C., Tian, J., Wan, S., Qian, Z., Gu, Y., Chen, W. R., & Wang, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2072 · Cited by 84
Pan, S., Liu, Y., Liu, Q., Xiao, Y., Liu, B., Ren, X. S., Qi, X., Zhou, H., Zeng, C., & Li, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.02.004 · Cited by 84
Wang, Z.-Q., Bachvarova, M., Morin, C., Plante, M., Gregoire, J., Renaud, M., Sebastianelli, A., & Bachvarov, D. R. (2014) · Oncotarget · doi:10.18632/oncotarget.1652 · Cited by 83
Lazar, M. N., Noonan, V. L., Rebustini, I. T., Walker, J. L., Menko, A. S., & Kukuruzinska, M. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4512 · Cited by 81
Kamigaito, T., Okaneya, T., Kawakubo, M., Shimojo, H., Nishizawa, O., & Nakayama, J. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.56 · Cited by 81
Defense and Adaptation: The Complex Inter-Relationship between Campylobacter jejuni and Mucus
Alemka, A., Corcionivoschi, N., & Bourke, B. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00015 · Cited by 80
Liu, B., Pan, S., Xiao, Y., Liu, Q., Xu, J., & Li, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1367-9 · Cited by 80
GALNT14 mediates tumor invasion and migration in breast cancer cell MCF‐7
Huanna, T., Tao, Z., Wang, X., Longfei, A., Xie, Y., Jianhua, W., Cuifang, Z., Manjing, J., Wenjing, C., Shaochuan, Q., et al. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22186 · Cited by 78
Tsai, C.-H., Tzeng, S., Chao, T., Tsai, C.-Y., Yang, Y., Lee, M., Hwang, J.-J., Chou, Y., Tsai, M., Cha, T., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0641 · Cited by 78
Li, Z., Yamada, S., Inenaga, S., Imamura, T., Wu, Y., Wang, K.-Y., Shimajiri, S., Nakano, R., Izumi, H., Kohno, K., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.166 · Cited by 76
Zhou, Z., Mondal, M. A., Liao, G., & Guo, Z. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00390j · Cited by 75
Clinical Relevance of Sialyltransferases ST6GAL-I and ST3GAL-III in Gastric Cancer
Gretschel, S., Haensch, W., Schlag, P. M., & Kemmner, W. (2003) · Oncology · doi:10.1159/000072339 · Cited by 74
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer
Lin, M., Chien, P.-H., Wu, H., Chen, S., Juan, H., Lou, P., & Huang, M. (2018) · Oncogene · doi:10.1038/s41388-018-0375-0 · Cited by 74
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
Han, C., Bellone, S., Siegel, E. R., Altwerger, G. H., Menderes, G., Bonazzoli, E., Egawa‐Takata, T., Pettinella, F., Bianchi, A., Riccio, F., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.03.050 · Cited by 71
Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites
Cherepanova, N. A., Venev, S. V., Leszyk, J., Shaffer, S. A., & Gilmore, R. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201904004 · Cited by 71
Hung, J., Huang, J. C., Lin, Y.-C., Huang, M.-J., Lee, P., Lai, H., Liang, J., & Huang, M. (2014) · Oncotarget · doi:10.18632/oncotarget.1815 · Cited by 69
Cai, H., Huang, Z., Shi, L., Zhao, Y., Kunz, H., & Li, Y. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201100217 · Cited by 69
Bassagañas, S., Carvalho, S., Dias, A. M., Pérez-Garay, M., Ortiz, M., Figueras, J., Reis, C. A., Pinho, S. S., & Peracaula, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098595 · Cited by 69
Li, W., Zhao, T., Xu, H., Wang, Z.-N., Xu, Y., Han, Y., Song, Y., Wu, J.-H., Xu, H., Yin, S., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5331-z · Cited by 69
Tan, K.-P., Ho, M., Cho, H.-C., Yu, J., Hung, J., & Yu, A. L.-T. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.243 · Cited by 68
Harosh-Davidovich, S. B., & Khalaila, I. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.024 · Cited by 68
Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells
Lai, T.-Y., Chen, I., Lin, R., Liao, G., Yeo, H.-L., Ho, C., Wu, J., Chang, N., Lee, A. C.-L., & Yu, A. L.-T. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0145-y · Cited by 68
Fernandes, E., Sores, J., Cotton, S., Peixoto, A., Ferreira, D., Freitas, R., Reis, C. A., Santos, L. L., & Ferreira, J. A. (2020) · Theranostics · doi:10.7150/thno.42480 · Cited by 68
Assessment of Chemoselective Neoglycosylation Methods Using Chlorambucil as a Model
Goff, R. D., & Thorson, J. S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101024j · Cited by 66
Berois, N., Mazal, D., Ubillos, L., Trajtenberg, F., Nicolas, A., Sastre‐Garau, X., Magdelénat, H., & Osinaga, E. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6783.2005 · Cited by 66
Chugh, S., Meza, J., Sheinin, Y. M., Ponnusamy, M. P., & Batra, S. K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.116 · Cited by 66
Cotton, S., Azevedo, R., Gaiteiro, C., Ferreira, D., Lima, L., Peixoto, A., Fernandes, E., Neves, M., Neves, D., Amaro, T., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12035 · Cited by 66
Kitada, S., Yamada, S., Kuma, A., Ouchi, S., Tasaki, T., Nabeshima, A., Noguchi, H., Wang, K.-Y., Shimajiri, S., Nakano, R., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.331 · Cited by 64
Freire, T., Berois, N., Sóñora, C., Varangot, M., Barrios, E., & Osinaga, E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21959 · Cited by 63
Che, M., Huang, J. C., Hung, J., Lin, Y.-C., Huang, M.-J., Lai, H., Hsu, W., Liang, J., & Huang, M. (2014) · Oncotarget · doi:10.18632/oncotarget.1981 · Cited by 62
Li, J., Xu, J., Li, L., Ianni, A., Kumari, P., Liu, S., Sun, P., Braun, T. W., Tan, X., Xiang, R., et al. (2020) · Theranostics · doi:10.7150/thno.43865 · Cited by 62
Briasoulis, E. C., Judson, I. R., Pavlidis, N. A., Beale, P. J., Wanders, J., Groot, Y., Veerman, G., Schuessler, M., Niebch, G., Siamopoulos, K. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3535 · Cited by 61
Lazar, M. N., Rebustini, I. T., Walker, J. L., & Kukuruzinska, M. A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.008 · Cited by 60
The other side of TGF-β superfamily signal regulation: thinking outside the cell
Gumienny, T. L., & Padgett, R. W. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00615-x · Cited by 60
GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
Berois, N., Gattolliat, C., Barrios, E., Capandeguy, L., Douc‐Rasy, S., Valteau‐Couanet, D., Bénard, J., & Osinaga, E. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.192328 · Cited by 59
Honma, R., Kinoshita, I., Miyoshi, E., Tomaru, U., Matsuno, Y., Shimizu, Y., Takeuchi, S., Kobayashi, Y., Kaga, K., Taniguchi, N., et al. (2015) · Oncology · doi:10.1159/000369495 · Cited by 58
Zaleski, M., Kobilay, M., Schroeder, L., Debald, M., Semaan, A., Hettwer, K., Uhlig, S., Kuhn, W. C., Hartmann, G., & Holdenrieder, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25077 · Cited by 58
N-Glycosylation Gene DPAGT1 Is a Target of the Wnt/β-Catenin Signaling Pathway
Sengupta, P. K., Bouchie, M. P., & Kukuruzinska, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149195 · Cited by 57
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
Okamoto, T., Yoneyama, M. S., Hatakeyama, S., Mori, K., Yamamoto, H., Koie, T., Saitoh, H., Yamaya, K., Funyu, T., Fukuda, M., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1189 · Cited by 57
N-glycans of growth factor receptors: their role in receptor function and disease implications
Takahashi, M., Hasegawa, Y., Gao, C., Kuroki, Y., & Taniguchi, N. (2016) · Clinical Science · doi:10.1042/cs20160273 · Cited by 57
Cornelissen, L. A. M., Blanas, A., Zaal, A., van der Horst, J. C., Kruijssen, L. J. W., O’Toole, T. G., van Kooyk, Y., & van Vliet, S. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01622 · Cited by 57
Tevethia, M. J., Bonneau, R. H., Griffith, J. W., & Mylin, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8157-8166.1997 · Cited by 56
Yuan, Q., Chen, X., Han, Y., Lei, T., Wu, Q., Yu, X., Wang, L., Fan, Z., & Wang, S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31737 · Cited by 56
Akita, K., Yoshida, S., Ikehara, Y., Shirakawa, S., Toda, M., Inoue, M., Kitawaki, J., Nakanishi, H., Narimatsu, H., & Nakada, H. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182473292 · Cited by 54
Thomas, D., Sagar, S., Caffrey, T. C., Grandgenett, P. M., & Radhakrishnan, P. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14572 · Cited by 54
Self-citationRole of fucosyltransferase IV in epithelial–mesenchymal transition in breast cancer cells
Yang, X., Liu, S., & Yan, Q. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.241 · Cited by 53
Grosso, F., Mariano, M. D., Passoni, L., Luksch, R., Tonini, G. P., & Longo, L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-525 · Cited by 53
The biosynthesis of branched O-glycans.
Schachter, H., & Brockhausen, I. (1989) · PubMed · Cited by 53
Comparison of the lectin-binding pattern in different human melanoma cell lines
Lityń́ska, A., Przybyuulo, M., Pocheć, E., Hoja-Łukowicz, D., Ciouulczyk, D., Laidler, P. M., & Gil, D. (2001) · Melanoma Research · doi:10.1097/00008390-200106000-00001 · Cited by 52
Sindrewicz, P., Lian, L., & Yu, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00079 · Cited by 51
Ponath, P. D., Menezes, D. L. D., Pan, C., Chen, B. Y., Oyasu, M., Strachan, D. C., LeBlanc, H. N., Sun, H., Wang, X.-T., Rangan, V. S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0018 · Cited by 50
Expression of tumor-associated antigens in breast cancer subtypes
Curigliano, G., Bagnardi, V., Ghioni, M., Louahed, J., Brichard, V. G., Lehmann, F. F., Marra, A., Trapani, D., Criscitiello, C., & Viale, G. (2019) · The Breast · doi:10.1016/j.breast.2019.12.002 · Cited by 50
Yu, S., Fan, J., Liu, L., Zhang, L., Wang, S., & Zhang, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.002 · Cited by 49
Tamura, F., Sato, Y., Hirakawa, M., Yoshida, M., Ono, M., Osuga, T., Okagawa, Y., Uemura, N., Arihara, Y., Murase, K., et al. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0454-z · Cited by 49
Shao, K., Chen, Z. Y., Gautam, S., Deng, N. H., Zhou, Y. L., & Wu, X. (2015) · Glycobiology · doi:10.1093/glycob/cwv089 · Cited by 48
Reconstitution of the lipid-linked oligosaccharide pathway for assembly of high-mannose N-glycans
Li, S.-T., Lu, T.-T., Xu, X., Ding, Y., Li, Z., Kitajima, T., Dean, N., Wang, N., & Gao, X. (2019) · Nature Communications · doi:10.1038/s41467-019-09752-3 · Cited by 48
Liu, C., Hu, R., Huang, M.-J., Lai, I., Chen, C., Lai, H., Wu, Y., & Huang, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094995 · Cited by 47
Carvalho, S., Oliveira, T., Bartels, M. F., Miyoshi, E., Pierce, M., Taniguchi, N., Carneiro, F., Seruca, R., Reis, C. A., Strahl, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11245 · Cited by 47
Fang, R., Xu, F., Shi, H., Wu, Y., Cao, C., Li, H., Ye, K., Zhang, Y., Liu, Q., Zhang, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1146-2 · Cited by 46
Brooks, S. A., Carter, T. M., Bennett, E., Clausen, H., & Mandel, U. (2007) · Acta Histochemica · doi:10.1016/j.acthis.2007.02.009 · Cited by 45
Ferreira, I., Carrascal, M. A., Mineiro, A. G. A. F., Bugalho, A., Borralho, P., Silva, Z., Dall’Olio, F., & Videira, P. A. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4886 · Cited by 44
Puranik, A. S., Pao, L. P., White, V. M., & Peppas, N. A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.007 · Cited by 43
β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3– N -Glycan Complex
Kariya, Y., Oyama, M., Hashimoto, Y., Gu, J., & Kariya, Y. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0365 · Cited by 43
Abdel‐Aal, A. M., Elnaggar, D. H., Zaman, M., Batzloff, M. R., & Tóth, I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300822g · Cited by 42
Yuan, Y., Wu, L., Shen, S., Wu, S., & Burdick, M. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.071 · Cited by 42
Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer
Noda, M., Okayama, H., Kofunato, Y., Chida, S., Saito, K., Tada, T., Ashizawa, M., Nakajima, T., Aoto, K., Kikuchi, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200315 · Cited by 42
Jassam, S. A., Maherally, Z., Ashkan, K., Pilkington, G. J., & Fillmore, H. L. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03188-x · Cited by 42
Sengupta, P. K., Bouchie, M. P., Lazar, M. N., Yang, H.-Y., & Kukuruzinska, M. A. (2012) · Journal of Cell Science · doi:10.1242/jcs.113035 · Cited by 41
Zhou, Z., Mandal, S. S., Liao, G., Guo, J., & Guo, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-11500-w · Cited by 40
Lahdaoui, F., Messager, M., Vincent, A., Hec, F., Gandon, A., Warlaumont, M., Renaud, F., Leteurtre, E., Piessen, G., Jonckheere, N., et al. (2017) · Biochemical Journal · doi:10.1042/bcj20170348 · Cited by 40
Park, S., Lim, J., Chun, J. N., Lee, S., Kim, T. I., Kim, D., Kim, S., Bae, D., Bae, S. M., So, I., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4953 · Cited by 40
hCLP46 regulates U937 cell proliferation via Notch signaling pathway
Ma, W., Du, J., Chu, Q., Wang, Y., Liu, L., Song, M., & Wang, W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.124 · Cited by 39
Kumar, P., Shustov, G. V., Liang, H., Khlebnikov, V., Zheng, W., Yang, X., Cheeseman, C. I., & Wiebe, L. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2017336 · Cited by 39
Hamester, F., Legler, K., Wichert, B., Kelle, N., Eylmann, K., Roßberg, M., Ding, Y., Kuerti, S., Schmalfeldt, B., Milde‐Langosch, K., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0607-2 · Cited by 39
Cheng, L., Cao, L. L., Wu, Y., Xie, W., Li, J., Guan, F., & Tan, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00929 · Cited by 37
van Tol, W., Wessels, H. J. C. T., & Lefeber, D. J. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.12.006 · Cited by 36
Josić, D., Martinović, T., & Pavelić, K. (2018) · Electrophoresis · doi:10.1002/elps.201800238 · Cited by 35
Radhakrishnan, P., Grandgenett, P. M., Mohr, A. M., Bunt, S. K., Yu, F., Chowdhury, S., & Hollingsworth, M. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28322 · Cited by 34
Self-citationJin, S., & Chung, J. H. (2018) · Bioscience Reports · doi:10.1042/bsr20171641 · Cited by 34
Cited by
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Xu, X., Peng, Q., Jiang, X., Tan, S., Yang, Y., Yang, W., Han, Y., Chen, Y., Oyang, L., Lin, J., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01020-1 · Cited by 276
Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications
Qusairy, Z., & Rada, M. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05303-1 · Cited by 16
Unraveling the glycosylated immunopeptidome with HLA-Glyco
Bedran, G., Polasky, D. A., Hsiao, Y., Yu, F., da Veiga Leprevost, F., Alfaro, J. A., Cieslik, M., & Nesvizhskii, A. I. (2023) · Nature Communications · doi:10.1038/s41467-023-39270-2 · Cited by 15
Yingli, H., Ping, Y., Jun, Y., & Xingwang, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167853 · Cited by 7
Metadata
- Authors
- Thomas, D., Rathinavel, A. K., & Radhakrishnan, P.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 1875
- Issue
- 1
- Pages
- 188464
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W3097586971
- Cited by
- 372
- References
- 222
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.